Editor of Patient Care Online.
Updated Novavax COVID-19 Vaccine Authorized by FDA to Protect Against Current Variants
The Novavax COVID-19 vaccine is refreshed with 2023-2024 formula targeting the XBB.1.5 strain.
Daily Dose: Biosimilar Liraglutide Found Safe, Effective for Use in Patients with T2D
Your daily dose of the clinical news you may have missed.
High Consumption of Ultraprocessed Foods Linked to Increased Risk of Depression
Results of a new study showed that greater intake of ultraprocessed foods, particularly artificial sweeteners and artificially sweetened beverages, was linked to a higher risk for depression.
Daily Dose: Oral Menopausal Hormone Therapy Associated with Higher Risk of NAFLD
Primary Care Follow-Up After Emergency Surgery May Help Prevent Readmissions, Improve Patient Outcomes
Results from a new study of Medicare beneficiaries admitted for an emergency general surgery show the odds of 30-day readmission was 67% lower for those with follow-up visit.
Daily Dose: Waist-to-Hip Ratio Better Predictor for Mortality than BMI?
Obesity Expert to Primary Care Clinicians: Keep Learning and Know When to Prescribe Antiobesity Drugs
Sandra Christensen, MSN, ARNP, gives her top strategies on patient selection for treatment with antiobesity medications and how to choose the right drugs for patients.
Daily Dose: Long-COVID Rehabilitation Interventions
Investigational Nasal Spray Found Safe, Effective for Self-Treatment of Paroxysmal Supraventricular Tachycardia
Etripamil 70 mg nasal spray restored heart rate within 30 minutes in approximately 60% of PSVT episodes, report authors of new study.
Daily Dose: Fatigue More Common in Chronic vs Episodic Migraine
Pegozafermin Receives Breakthrough Therapy Designation for Nonalcoholic Steatohepatitis
The US Food and Drug Administration granted BTD to pegozafermin for the treatment of patients with NASH.
Daily Dose: Dupilumab Potent Against Uncontrolled COPD with Type 2 Inflammation
ACIP Recommends Maternal RSV Vaccine to Protect Newborns
Members of the ACIP voted on Friday to recommend Pfizer’s maternal bivalent RSVpreF vaccine to protect newborns from severe RSV illness.
Daily Dose: Early Childhood Obesity Treatment Found Effective Long-Term
Empagliflozin Wins FDA Approval for the Treatment of Adults with CKD
Empagliflozin is approved to lower the risk of sustained decline in eGFR, end-stage kidney disease, CV death, and hospitalization in adults with CKD at risk of progression.
Daily Dose: Antihypertensive Treatment Throughout Late Life Lowers Risk of Dementia
Mental Health in the US: Happiest States in 2023
What state has highest share of adult depression? Or the lowest divorce rate? Find the answers and more insights from a nationwide analysis, here.
Daily Dose: Risky Alcohol Use Among US Adults Prescribed Alcohol-Interactive Medications
Early Initiation of Childhood Obesity Treatment Linked to Better Weight Outcomes Over Time
An intensive parent-support early childhood obesity intervention program led to better weight status outcomes in the long-term compared to standard therapy, report study authors.
Daily Dose: Parental Stigma Toward HPV Vaccine Barrier to Adolescent Uptake
Antiobesity Medications: Expert Compares Benefits, Drawback Among Classes
Obesity specialist Sandra Christensen, MSN, ARNP, compares the benefits and drawbacks among older antiobesity drugs and newer GLP-1RAs liraglutide and semaglutide 2.4 mg.
Daily Dose: Efficacy of a Remote Bilingual Program in Reducing Uncontrolled HTN
Antihypertensive Treatment Throughout Late Life May Reduce Risk of Dementia
Results from a new study show that older adults with untreated hypertension had a 42% increased risk of dementia vs healthy controls.
Daily Dose: High Blood Pressure While Lying Down Raises Risk for CVD Events
Daily Dose: More Steps a Day Linked to Better Health for Patients with Heart Failure
Your daily dose of clinical news you may have missed.
Antiobesity Medications: Expert Discusses Older, Newer Therapies
Obesity specialist Sandra Christensen, MSN, ARNP, details the differences between older antiobesity medications and newer GLP-1RAs liraglutide and semaglutide 2.4 mg.
Daily Dose: COVID-19 Vaccination Decreases Symptoms of Long COVID
Remote Bilingual Program Proves Effective in Controlling Blood Pressure in Underserved Population
New research presented at Hypertension 2023 showed a novel digital bilingual hypertension control program improved BP control rates by more than 30%.
Daily Dose: Worldwide Burden of Atrial Fibrillation Doubled Over 30 Years
Hypertension While Lying Down Linked to Elevated Risk for CVD Events
Persons with HTN while in a supine position had a higher risk for CVD even if they did not have HTN while seated, according to new research presented at Hypertension 2023.
